Phase II Iressa Versus Vinorelbine (INVITE)

NCT00256711 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

192

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small-Cell Lung Carcinoma

Interventions

DRUG: Gefitinib
DRUG: Vinorelbine

Sponsor

AstraZeneca